Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma

Table 1

Demographic information of enrolled patients ().

Category	Number of subjects
Age group
18–33	0
34–49	3
50–65	13
>65	11
Gender
Male	18
Female	9
Race
Caucasian	24
Asian	0
Hispanic	2
African American	1
Other	0